Major neurocognitive disorder is the clinical term for what most people know as dementia. The DSM-5, the standard diagnostic manual used in psychiatry, introduced this terminology to more precisely describe a condition where cognitive decline becomes severe enough to interfere with a person’s ability to live independently. The older term “dementia” is still widely used and refers to the same thing. About 1 in 9 Americans over age 65 lives with the most common form, Alzheimer’s dementia, and that percentage climbs steeply with age.
How It’s Defined and Diagnosed
A diagnosis of major neurocognitive disorder requires two things happening together: significant cognitive decline and loss of functional independence. On formal testing, a person’s performance needs to fall roughly in the bottom 3% compared to others of similar age and background, in at least one area of thinking. But poor test scores alone aren’t enough. The person also has to be losing the ability to handle everyday tasks they previously managed on their own.
That second requirement, functional decline, is what separates major neurocognitive disorder from its milder counterpart. In mild neurocognitive disorder (roughly equivalent to what’s often called mild cognitive impairment), a person may notice their thinking has slipped and need to put in more effort or use workarounds, but they can still get through daily life independently. Once cognitive problems start genuinely interfering with independence, the diagnosis shifts to major.
One important update in the current diagnostic framework: memory loss is no longer the defining feature. Decline in any cognitive area can qualify. This matters because some forms of dementia, like frontotemporal degeneration, primarily affect personality, decision-making, or language rather than memory.
The Six Cognitive Domains
The DSM-5 identifies six broad areas of thinking that can be affected:
- Complex attention: the ability to stay focused, especially when there are distractions or multiple things happening at once.
- Learning and memory: taking in new information, retaining it, and recalling it later.
- Executive function: planning, organizing, solving problems, and switching between tasks.
- Language: finding words, following conversations, and understanding or producing speech.
- Visuospatial ability: judging distances, recognizing faces, navigating familiar routes, or copying a drawing.
- Social cognition: reading other people’s emotions, understanding social cues, and behaving appropriately in social situations. Loss of empathy is a hallmark of frontotemporal degeneration, for example.
A person doesn’t need to decline in all six. Significant impairment in even one domain, combined with functional loss, is enough for a diagnosis.
What “Loss of Independence” Looks Like
Functional independence is measured by a person’s ability to handle two categories of tasks: basic activities and more complex instrumental activities. The complex ones tend to slip first. These include managing finances, preparing meals, keeping track of medications, using transportation, shopping, doing housework, and communicating by phone or mail. These all require organizational thinking, planning ahead, and sequencing steps correctly.
As the condition progresses, basic activities become affected too. These are more fundamental: bathing, dressing, feeding oneself, using the toilet, and moving around safely. The DSM-5 uses these functional milestones to classify severity within major neurocognitive disorder. Mild severity means a person struggles mainly with complex tasks like paying bills or cooking. Moderate severity means basic daily functions like getting dressed are impaired. Severe means a person is fully dependent on others for care.
Common Causes
Major neurocognitive disorder isn’t a single disease. It’s a syndrome, a pattern of decline, that can be caused by many different conditions. The DSM-5 lists 13 possible underlying causes. The most common by far is Alzheimer’s disease, which accounts for 70 to 80% of all cases. It primarily damages brain areas involved in memory and learning, though it eventually affects most cognitive functions.
Vascular disease is the next most common cause, responsible for about 15% of cases. This happens when reduced blood flow to the brain, often from small strokes or chronic blood vessel damage, kills brain tissue over time. Many older adults have a mix of Alzheimer’s and vascular damage contributing to their decline.
Lewy body disease accounts for roughly 5% of cases and produces a distinctive combination of fluctuating alertness, visual hallucinations, and movement problems similar to Parkinson’s disease. When combined with Parkinson’s disease dementia, Lewy body conditions represent the second most common degenerative cause in people over 65.
Other recognized causes include frontotemporal degeneration (which often strikes earlier, sometimes in a person’s 50s), traumatic brain injury, HIV infection, Huntington’s disease, prion diseases, and long-term substance or medication use. In some cases, multiple causes overlap.
How Common It Is
An estimated 6.9 million Americans age 65 and older are living with Alzheimer’s dementia alone. That number is projected to nearly double to 13.8 million by 2060 if no major medical breakthroughs change the trajectory. The risk rises sharply with age: about 5% of people aged 65 to 74 have Alzheimer’s dementia, 13.2% of those 75 to 84, and a full third of people 85 and older.
New cases follow a similar age pattern. Among people 65 to 74, roughly 4 out of every 1,000 develop Alzheimer’s dementia each year. By age 85 and older, that rate jumps to 76 per 1,000. These figures cover only Alzheimer’s; including vascular, Lewy body, and other forms would push the total prevalence of major neurocognitive disorder higher.
Behavioral and Psychological Changes
Cognitive decline is the core of the diagnosis, but behavioral changes are often what families notice first and find most distressing. Apathy, where a person loses interest and motivation, is extremely common. So are agitation, depression, delusions, and hallucinations. In many cases, these behavioral shifts are the primary reason families seek medical help, even before the cognitive decline is formally recognized.
How It’s Assessed
Diagnosis typically combines a clinical interview, input from someone who knows the person well (a spouse, adult child, or close friend), and formal cognitive testing. Screening tools administered by a healthcare professional can flag problems quickly, but a fuller neuropsychological assessment, a battery of tests that measures each cognitive domain separately, provides the detailed picture needed to confirm a diagnosis and identify which areas are most affected. Brain imaging and blood work help narrow down the underlying cause.
Managing Symptoms
There is no cure for most causes of major neurocognitive disorder, but several strategies can help manage symptoms and maintain quality of life for longer. Exercise training has shown benefits for both physical function and cognition. Cognitive stimulation, which includes activities like word games, puzzles, discussing current events, music, and hands-on tasks like baking or gardening, helps keep thinking and memory engaged.
Simple lifestyle measures such as balance exercises and anti-inflammatory diets have also been linked to modest cognitive improvements. Medications that aim to slow memory decline exist, though their benefits are limited. When these drugs are considered, the decision typically involves weighing realistic expectations about how much improvement to expect against the possibility of side effects. For behavioral symptoms like agitation or depression, targeted treatment can significantly improve day-to-day comfort for both the person affected and their caregivers.
Because the condition is progressive, management also involves planning ahead: setting up support systems, simplifying daily routines, addressing safety concerns like driving and cooking, and gradually increasing the level of care as needs change.